Newsflash:
- Early Study Suggests Nanodiamonds Safe for Implants
- Report Decries Lack of Price Transparency
- Study Finds No Drug-Drug Interaction Between Aggrenox 25mg/200mg Capsules and Omeprazole
- Merck Provides Update on Development Program for Suvorexant, an Investigational Orexin Receptor Antagonist for the Treatment of Insomnia
- Merck KGaA Licenses Pancreatic Cancer Drug From Threshold
- EDARBYCLOR Now Available in U.S. Pharmacies for Patients with Hypertension
Advertise With Us
As the nation’s premier online news, information, and education network for pharmacists, Pharmacist e-Link remains the innovative answer for manufacturers and suppliers to communicate and interact with pharmacists.
We offer variety of programming options to get your message into the Pharmacy Community:
Contacts:
Our Sponsors:
Sitemap
© Pharmacist e-Link
